Reports

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…

For product managers, market insight leaders, marketing teams, and business development professionals, knowing how scientists experience your brand, and how that experience stacks up against key competitors, is essential for prioritizing investment, sharpening positioning, and uncovering growth opportunities. As life science researchers continue to elevate their experience expectations, suppliers need an objective, external view of…

IMV’s 2026 CT Market Outlook Report analyzes U.S. CT procedure volumes, installed base, manufacturer market share, purchase plans, and site operations trends from a survey of 350 professionals.

SDi’s 2026 Laboratory Automation Markets report analyzes automation technologies, suppliers, and market dynamics across liquid handling, robotics, informatics, and biorepository systems in laboratories worldwide.

Kalorama’s World Market for Clinical Sequencing and Sequencing-Based IVD Products, 2026 analyzes clinical sequencing instruments, consumables, software, and diagnostic products, with forecasts through 2030.

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

Kalorama’s 2026 report analyzes the global mass spectrometry market in IVD, forecasting nearly double growth by 2030 across instruments, IVD kits, and clinical diagnostic applications.

The 2026 SDi Global Assessment Datastream is only available to those who have purchased The 2026 Global Assessment Report: The Analytical and Life Science Instrumentation Industry.

The world runs on roughly 150 billion diagnostic tests a year—and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition quantifies that divergence with precision, tracking global procedure volumes segment by segment and region by region as the diagnostics industry completes its transition out of the pandemic era.…

SDi’s Market Landscape: Sequencing report analyzes the sequencing market’s sizing, five-year forecasts, vendor shares, and the litigation and regulatory trends shaping Illumina, Oxford Nanopore, PacBio, and emerging entrants.

IMV’s 2026 Oncology in Diagnostic Imaging Market Outlook Report covers procedure volumes, installed base, manufacturer share, purchase plans, and AI adoption across eight modalities, based on a survey of 215 U.S. imaging professionals conducted through June 2026.

Kalorama’s 105-page clinical proteomics report sizes the market by technology and region through 2030, covering mass spectrometry, high-plex affinity assays, digital immunoassays, and spatial proteomics, with company profiles of 16 vendors and analysis of deals, approvals, and trends from 2021 to 2026.